| scholarly article | Q13442814 |
| P2093 | author name string | Ferric C Fang | |
| P2860 | cites work | Plasmid-mediated quinolone resistance: a multifaceted threat | Q24645356 |
| Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections | Q28084595 | ||
| Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus | Q28343420 | ||
| Revised Ciprofloxacin Breakpoints for Salmonella: Is it Time to Write an Obituary? | Q30357554 | ||
| Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi | Q33769931 | ||
| Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin | Q33798473 | ||
| The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy | Q33945463 | ||
| PMQR genes oqxAB and aac(6')Ib-cr accelerate the development of fluoroquinolone resistance in Salmonella typhimurium | Q34280271 | ||
| Antimicrobial resistance in Salmonella enterica Serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam | Q34596678 | ||
| Fluoroquinolone antimicrobial agents | Q34613302 | ||
| Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
| Plasmid-mediated Quinolone Resistance among Non-TyphiSalmonella entericaIsolates, USA | Q35804933 | ||
| Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica | Q36173968 | ||
| Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India | Q36584708 | ||
| Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States | Q37190695 | ||
| Antibiotic resistance--what's dosing got to do with it? | Q37205795 | ||
| Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium | Q37320182 | ||
| Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin | Q37643475 | ||
| In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards | Q38023251 | ||
| Declining susceptibilities of gram-negative bacteria to the fluoroquinolones: effects on pharmacokinetics, pharmacodynamics, and clinical outcomes | Q38056640 | ||
| A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan | Q38239344 | ||
| Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones | Q39732658 | ||
| Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae | Q40556003 | ||
| Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment | Q40642659 | ||
| A case of ciprofloxacin-resistant typhoid fever | Q40726796 | ||
| Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi | Q40810695 | ||
| Trends in bacterial resistance to fluoroquinolones | Q41311555 | ||
| Performance of Etest and disk diffusion for detection of ciprofloxacin and levofloxacin resistance in Salmonella enterica | Q41684776 | ||
| Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. | Q42747648 | ||
| Evaluation of Surrogate Disk Tests for Detection of Ciprofloxacin and Levofloxacin Resistance in Clinical Isolates of Salmonella enterica | Q43214932 | ||
| Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). | Q43260620 | ||
| Joint Effects of Topoisomerase Alterations and Plasmid-Mediated Quinolone-Resistant Determinants inSalmonella entericaTyphimurium | Q43914864 | ||
| Co-spread of oqxAB and blaCTX-M-9G in non-Typhi Salmonella enterica isolates mediated by ST2-IncHI2 plasmids | Q44978605 | ||
| Inappropriate use of oral ciprofloxacin | Q45070443 | ||
| Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6')-Ib-cr | Q46736529 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom | Q47754927 | ||
| Revised ciprofloxacin breakpoints for Salmonella Typhi: its implications in India | Q49998870 | ||
| International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries | Q50043202 | ||
| High prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr amongst Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China | Q50044515 | ||
| Multidrug-resistant Salmonella typhi in India | Q50125020 | ||
| Resistance to fluoroquinolones in Salmonella non-typhi and Campylobacter spp | Q50171701 | ||
| Treatment of multiresistant Salmonella typhi with oral ciprofloxacin | Q50200040 | ||
| Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. | Q54042955 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3401-3404 | |
| P577 | publication date | 2015-08-26 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected]. | |
| P478 | volume | 53 |
| Q57945279 | Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing |
| Q40764604 | Molecular Characterization of Intermediate Susceptible Typhoidal Salmonella to Ciprofloxacin, and its Impact |
| Q41126261 | Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects |
Search more.